In this case study Dr. José Bines discusses the clinical potential of CDK4/6 inhibitors in Breast Cancer. Take the Case Study Quiz: Patient description 25 yow, premenopausal, single, architecture student, without comorbidities. Family history includes a paternal grandmother and 2 paternal aunts with breast cancer at a young age. A gBRCA2 pathogenic mutation was documented. […]

In this case study Dr. Rachel Würstlein discusses the clinical potential of CDK4/6 inhibitors in Breast Cancer. Take the Case Study Quiz: What is the most common side effects of Abemaciclib? QT prolongation Fatigue Neutropenia Diarrhea Elevated liver enzymes None Time’s upCancel

In this case study Prof. Giuseppe Curigliano discusses the clinical potential of CDK4/6 inhibitors in Breast Cancer. Take the Case Study Quiz: Patient description Patient: Ms. S.R., a 42-year-old female Diagnosis: Invasive Ductal Carcinoma of the right breast Clinical Stage: T2N2 (5/15) M0 (Stage I) Hormone Receptor Status: ER-positive, PR-positive, HER2-negative No significant comorbidities Case